Butyrate Adjuvant Therapy for Type 1 Diabetes
NCT03999853
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Type1diabetes
Interventions
DRUG:
BKR-017
Sponsor
Mayo Clinic
Collaborators
[object Object]
[object Object]